Download FREE Sample
Report Overview
A nutraceutical CDMO (Contract Development and Manufacturing Organization) is a company that provides outsourced services for the development, formulation, manufacturing, and packaging of nutraceutical products on behalf of brand owners and health supplement companies. 
To learn more about the research report, download a sample report.
Rising demand for nutraceutical products driving the growth of the nutraceutical CDMO market
Nutraceutical products encompass a wide range of substances and food items that offer medical or health benefits beyond basic nutrition, aiming to support disease prevention and treatment. As dietary habits evolve, the demand for these products continues to rise, driven by increasing consumer awareness, the growing prevalence of non-communicable diseases, and escalating healthcare costs. Additionally, the consumption of multivitamins is expected to surge as consumers prioritize immune system support, a trend that gained significant momentum during the COVID-19 pandemic and is likely to persist in the future. To meet these shifting consumer demands, nutraceutical companies are increasingly partnering with CDMOs for cost-effective, large-scale production, advanced R&D capabilities, and regulatory compliance. With stringent FDA and global regulations, CDMOs provide essential expertise in quality assurance, labeling, and clinical trials, ensuring that brands deliver high-quality, compliant products to market. The rapid expansion of e-commerce and direct-to-consumer (DTC) brands has further accelerated the need for private-label manufacturing and turnkey solutions. As the nutraceutical industry continues its rapid growth, CDMOs play a vital role in helping brands scale efficiently, develop innovative formulations, and cater to the increasing consumer demand for health and wellness solutions. 
To learn more about the research report, download a sample report.
Growing outsourcing trends in the nutraceutical industry fuel its demand
Nutraceuticals and dietary ingredients such as probiotics, folic acid, and fish oil offer significant health benefits, including supporting biological processes that help prevent chronic diseases, promoting healthy aging, and maintaining the body's structure and function. As nutraceutical companies capitalize on this growing market, many are turning to specialized CDMOs with expertise in fine chemicals. CDMOs provide end-to-end solutions, including R&D, formulation, raw material sourcing, production, packaging, and labeling, allowing companies to focus on branding, marketing, and distribution while outsourcing manufacturing complexities. This approach helps streamline production, reduce costs, and enhance product quality while ensuring compliance with industry regulations. Key ways CDMOs support the growth of nutraceutical companies include reduced capital investment, regulatory compliance expertise, advanced manufacturing capabilities, and efficient development cycles.
Competitive Landscape Analysis
The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~8% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Dosage Form, Service Type, and Company Size |
| Regional Scope |
|
| Key Companies Mapped | Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides thesize of the global nutraceutical CDMO market at theregional- and country-level from 2023 to 2030. The report further segments the market based on dosage form, service type, and company size.
- Market Size & Forecast (2023-2030), By Dosage Form, USD Million
- Tablets & Capsules
- Softgel
- Powder
- Others
- Market Size & Forecast (2023-2030), By Service Type, USD Million
- Product Formulation and Development
- Research & Development (R&D)
- Manufacturing and Packaging
- Regulatory Compliance
- Others
- Market Size & Forecast (2023-2030), By Company Size, USD Million
- Small Companies
- Mid-Sized Companies
- Large Companies
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the nutraceutical CDMO market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the nutraceutical CDMO market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
